Nutex Health
NUTX· Services· Fiscal year ends in December
CEO pay in FY2023Stock -90.5% in FY2023
Thomas T. Vo is the CEO of Nutex Health and was paid $1.0M in FY2023 (Dec), up 7%.
Pay$100 in the stock at the end of FY22 → $9
Executives6
See all- 1Thomas T. VoChief Executive OfficerFY2023
- 2Warren HosseinionPresidentFY2023
- 3Jon BatesChief Financial OfficerFY2022
- 4Joshua DeTillioFormer Chief Operating OfficerFY2023
- 5Michael ChangChief Medical Officer 6)Not disclosed
- 6Wesley BamburgCurrent Chief Operating OfficerNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allNutex Health paid its 3 named executives $1.8M in total in FY2023 (Dec). CEO Thomas T. Vo was paid $1.0M of that.
| Name | ||
|---|---|---|
| Thomas T. VoChief Executive Officer | ||
| Warren HosseinionPresident | ||
| Joshua DeTillioFormer Chief Operating Officer | Not disclosed | |
| Jon BatesChief Financial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Nutex Health. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board1
See all- Mitchell Creem, MHADirector · 1 yr on the boardIndependentAudit (Chair), Compensation, Nominating and Governance—Paid as an executive
The board of the latest proxy (FY2023).
Activity
Filings6
See all| Proxy statement | DEF 14A | Mar 13, 2026 | FY2025 |
| Annual report | 10-K | Mar 5, 2026 | FY2025 |
| Proxy statement | DEF 14A | Jun 2, 2025 | FY2024 |
| Annual report | 10-K | Mar 31, 2025 | FY2024 |
| Proxy statement | DEF 14A | May 6, 2024 | FY2023 |
| Annual report | 10-K | Mar 29, 2024 | FY2023 |